Whole Network Most Recent TOP10 Gene Therapy Microbiology Nanomedicine Stem Cells

 

Breast Cancer Vaccine Targeting HER-2/neu Over-expression

Filed in archive Drugs, Vaccines and Therapeutics by ruth on November 13, 2006

Breast Cancer Vaccine Targeting HER-2/neu Over-expression
Over the past few years, several genetic markers of breast cancer have been identified, such as BRCA, estrogen receptors, and HER-2/neu, all of which have been known to predict the severity of disease, recurrence and overall survival. Reasearchers are now using these findings to develop vaccines targeting these genetic markers.

In a study presented during the recently held meeting of the American Association for Cancer Research's Frontiers in Cancer Prevention Research in Boston, scientists evaluated the potentials of a new vaccine targeting the HER-2/neu over-expression in a type of early stage breast cancer known as DCIS (ductal carcinomas in situ, or early stage cancer formation in the breast's milk ductslinks).

Patients with HER-2/neu overexpression were given a therapy of dendritic cells (DC, which work with the B- and T-cells to trigger immune responses) that were treated with HER-2/neu to evoke an immune response. The participants received four weekly vaccinations into normal lymph nodes in their groins and were evaluated both pre- and post-vaccination for immune response, level of HER-2/neu expression, and cell infiltrates.


Results indicate that the positive response in nearly all patients, half of which showed markedly reduced levels of HER-2/neu expression following vaccination.

"The results demonstrate for the first time that this DC vaccination may have significant clinical activity against certain types of breast cancer," said Brian J. Czerniecki, M.D., of the University of Pennsylvania, and lead author of the study. "We are confident that targeted treatment with this vaccine may effectively fight not only DCIS, but may extend to prevention of breast cancer entirely."


Source: AACR

[Image: Normal breast with non-invasive ductal carcinoma in situ (DCIS) in an enlarged cross-section of the duct. Source: BreastCancer.org]


Advertisement


Permalink: Breast Cancer Vaccine Targeting HER-2/neu Over-expression
Tags: breast+cancer  vaccine  genetic+marker  genetics  gene+therapy  breast  targeting+over  over+expression 

Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/42354



Advertisement


Advertisement


CW ToolbarInstall
RSSrss   | See all blog subscribe options
Googlegoogle   |   What is RSS?
Yahoo!yahoo
AddthisAddThis Feed Button
BloglinesBloglines
Newsletter
Advertisement - Book yours here.

Use our search feature to look for other interesting posts

Just this blog Whole network
Advertisement -
Book yours here..


 
Advertisement
Book yours here.



  • Testimonials

  • 'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

    'I subscribe to your blog and have been enjoying your posts and perspective.'
  • Other blogs in the same channel in the Creative Weblogging Network

Advertisement -
Book yours here..






Advertisement - Book yours here..
 
Tagcloud: Biotech Hubs and Facilities Biotech/Science Blogs Corporate and Industrial News Diagnostics, Methodologies and Instrumentation Drugs, Vaccines and Therapeutics Energy, Environment and Ecology Food and Agriculture Gene Therapy Genomics, Proteomics and Bioinformatics Meetings and Other Events Microbiology Nanomedicine Other Biotechnology News Patents and Intellectual Property Rights Sponsored Post Stem Cells